Biphenotypic Immunohistochemical Features and NTRK1 Amplification in Intermediate Cell Carcinoma of the Liver.

genetics immunohistochemistry intermediate cell carcinoma liver cancer neurotrophic receptor tyrosine kinase 1 pathology

Journal

International journal of surgical pathology
ISSN: 1940-2465
Titre abrégé: Int J Surg Pathol
Pays: United States
ID NLM: 9314927

Informations de publication

Date de publication:
Aug 2023
Historique:
medline: 3 7 2023
pubmed: 9 12 2022
entrez: 8 12 2022
Statut: ppublish

Résumé

Intermediate cell carcinoma is one of the rarest forms of primary liver cancer comprising relatively monomorphic populations of neoplastic epithelial cells demonstrating simultaneous positivity of both hepatocyte and cholangiocyte immunohistochemical markers. Here in, we describe an adult male patient who underwent left hepatectomy for a large liver tumor. The pathological and immunohistochemical analysis revealed the malignant primary liver cancer with intermediate cell morphology and mixed immunophenotypic features consistent with intermediate cell carcinoma. Furthermore, the genomic profiling using the Next-generation sequencing (NGS) platform demonstrated that there is a novel amplification with copy number gain 12 (12 gene copies) in the Neurotrophic Receptor Tyrosine Kinase 1 (

Identifiants

pubmed: 36476133
doi: 10.1177/10668969221142043
doi:

Substances chimiques

Receptor, trkA EC 2.7.10.1

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

839-845

Auteurs

Subathra Radhakrishnan (S)

Cell Laboratory, National Foundation for Liver Research, Chennai, TN, India.

Catherine Ann Martin (CA)

Cell Laboratory, National Foundation for Liver Research, Chennai, TN, India.

Mukul Vij (M)

Department of Pathology, Dr Rela Institute and Medical Centre, Chennai, TN, India.

Lexmi Priya Raju (LP)

Department of Pathology, Dr Rela Institute and Medical Centre, Chennai, TN, India.

G Gowripriya (G)

Department of Pathology, Dr Rela Institute and Medical Centre, Chennai, TN, India.

Koustav Jana (K)

The Institute of Liver Disease & Transplantation, Dr Rela Institute and Medical Centre, Chennai, TN, India.

Ashwin Rammohan (A)

The Institute of Liver Disease & Transplantation, Dr Rela Institute and Medical Centre, Chennai, TN, India.

Dinesh Jothimani (D)

The Institute of Liver Disease & Transplantation, Dr Rela Institute and Medical Centre, Chennai, TN, India.

Ilankumaran Kaliamoorthy (I)

The Institute of Liver Disease & Transplantation, Dr Rela Institute and Medical Centre, Chennai, TN, India.

Vidya Harini Veldore (VH)

4baseCare Onco Solutions Pvt. Ltd., Bangalore, KA, India.

Mohamed Rela (M)

The Institute of Liver Disease & Transplantation, Dr Rela Institute and Medical Centre, Chennai, TN, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH